Headquarters
BERTEL JUNGIN AUKIO 1, ESPOO, ETELA-SUOMEN LAANI 02600, FI
ESPOO, ETELA-SUOMEN LAANI, FI
HERANTIS PHARMA OYJ
From the company
Herantis Pharma Plc is a clinical-stage biotechnology company developing neurorestorative therapies aimed at slowing or stopping the progression of Parkinson's disease. Its lead product HER-096 is a CDNF-derived peptidomimetic targeting multiple Parkinson's disease mechanisms. The company is listed on Nasdaq First North Growth Market Finland under the ticker HRTIS.
Products & services offered
Capabilities 3
Facilities
Send your requirements
Quantities, certifications, and timing.